n-(2-hydroxypropyl)methacrylamide has been researched along with Cancer of Skin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Connors, TA; Duncan, R; Satchi, R | 1 |
| Huang, Y; Li, L; Liu, Y; Sun, W; Wang, F; Zhou, Z | 1 |
| Mohanraj, S; Murugan, D; Rajiv, S; Rengarajan, A | 1 |
| David, A; Golan, M; Shamay, Y; Tyomkin, D | 1 |
4 other study(ies) available for n-(2-hydroxypropyl)methacrylamide and Cancer of Skin
| Article | Year |
|---|---|
PDEPT: polymer-directed enzyme prodrug therapy. I. HPMA copolymer-cathepsin B and PK1 as a model combination.
Topics: Animals; Area Under Curve; Cathepsin B; Combined Modality Therapy; Enzyme Activation; Half-Life; Infusions, Intravenous; Male; Melanoma; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Polymethacrylic Acids; Prodrugs; Skin Neoplasms | 2001 |
A novel α
Topics: Acrylamides; Animals; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; HeLa Cells; Humans; Hydrogen-Ion Concentration; Integrin alphaVbeta3; Ligands; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Peptides; Polymethacrylic Acids; Random Allocation; Skin Neoplasms | 2018 |
Anticancer activity of starch/poly[N-(2-hydroxypropyl)methacrylamide]: biomaterial film to treat skin cancer.
Topics: Acrylamides; Animals; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Camptothecin; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Delivery Systems; Humans; Nuclear Magnetic Resonance, Biomolecular; Skin Neoplasms; Spectroscopy, Fourier Transform Infrared; Starch; Thermogravimetry; Vero Cells | 2014 |
Assessing the therapeutic efficacy of VEGFR-1-targeted polymer drug conjugates in mouse tumor models.
Topics: Acrylamides; Animals; Antibiotics, Antineoplastic; Carcinoma, Lewis Lung; Cell Line; Cell Survival; Disease Models, Animal; Doxorubicin; Drug Carriers; E-Selectin; HT29 Cells; Humans; Melanoma, Experimental; Mice, Inbred C57BL; Skin Neoplasms; Treatment Outcome; Tumor Burden; Vascular Endothelial Growth Factor Receptor-1 | 2016 |